코리아중앙데일리: Pfizer가 백신개발에 거의 성공?

언젠가는 개발이 될 줄 알았지만, 이렇게나 빨리 될 줄은 몰랐다. 확실히 개발된 것은 아니고 3차 임상시험에서 플라시보효과를 본 사람들보다 백신 예방율이 90%달했다는 중간결과를 발표한 것이다. 미국 FDA 승인은 아마 12월 전으로 날 것 같고, 내년 후반기 정도에나 접종이 가능할 듯 하다.

​

[기사제목] Korea could obtain Pfizer's vaccine by first half of 2021, KDCA official says BY SHIM KYU-SEOK

​

1. obtain Pfizer's new coronavirus vaccine

2. highly promising early clinical trial results : 머가 일케 길어.... 임상시험은 영어로 clinical trial 이라고 한다는 것

3. to start inoculations : 백신 접종을 시작한다는 말

4. preliminary results: early results 대신에 쓰자.

5. far exceeding expections

6. set up a cold chain temperature-controlled supply system: 백신을 수입하려면 냉장 장치가 필요하다고 한다

7. devise an immunizaion strategy

8. the country is also in the final throes of efforts: 백신개발에서 마지막 단계의 산고, 엄청난 고통을 겪고 있는 한국

9. in poorly ventilated indoor facilities: 환기를 좀 자주 시켜야겠다.

10. the government's new five-tier social distancing scheme: 새로 5단계 사회적 거리두기 방안을 발표한 한국

​

기사요약: Pfizer released preliminary clinical trial results which were very promising, showing that it was 90 percent effective in comparison with placebo doses. Other countries are also expecting to get the vaccine delievered within several months and Korea is also trying to obtain the vaccine and it may take quite a long time to have people inoculated with the vaccine. The vaccine is expected to get the U.S FDA approval by December.

​

​

https://koreajoongangdaily.joins.com/2020/11/10/national/socialAffairs/Covid19-vaccine-Pfizer/20201110191400442.html

Korea could obtain Pfizer's vaccine by first half of 2021, KDCA official says

Korea is aiming to obtain Pfizer’s new coronavirus vaccine within the first half of 2021, Seoul’s health authorities announced Tuesday, after the U.S. pharmaceutical company revealed highly promising early clinical trial results.

koreajoongangdaily.joins.com